Migration, fate and in vivo imaging of adult stem cells in the CNS

Cell Death and Differentiation

Volumn 14, Issue 7, 2007, Pages 1336-1342

  Sykove E ^a,b   Jendelova P ^a,b  

^a INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; GRANULOCYTE COLONY STIMULATING FACTOR; IRON; MANGANESE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN ISCHEMIA; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL LABELING; CELL MIGRATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DEGENERATIVE DISEASE; HUMAN; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR IMAGING; MULTIPOTENT STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NANOPARTICLES; STAINING AND LABELING;

EID: 34250747913     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402140     Document Type: Review

References (61)

1. Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol 2005; 18: 59-64.
2. Dezawa M, Hoshino M, Nabeshima Y, Ide C. Marrow stromal cells: implications in health and disease in the nervous system. Curr Mol Med 2005; 5: 723-732.
3. Levy YS, Stroomza M, Melamed E, Otten D. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease. J Mol Neurosci 2004; 24: 353-386.
4. Taupin P. Adult neurogenesis in mammals. Curr Opin Mol Ther 2006; 8: 345-351.
5. Sohur US, Emsley JG, Mitchell BD, Macklis JD. Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1477-1497.
6. Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast Reconstr Surg 2006; 118 (Suppl 3): 121S-128S.
7. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 2006; 13: 77-81.
8. Tholpady SS, Llull R, Ogle RC, Rubin JP, Futrell JW, Katz AJ. Adipose tissue: Stem cells and beyond. Clin Plast Surg 2006; 33: 55-62, vi.
9. Teng L, Labosky PA. Neural crest stem cells. Adv Exp Med Biol 2006; 589: 206-212.
10. Watt FM, Lo Celso C, Silva-Vargas V. Epidermal stem cells: An update. Curr Opin Genet Dev 2006; 16: 518-524.
11. Morigi M, Benigni A, Remuzzi G, Imberti B. The regenerative potential of stem cells in acute renal failure. Cell Transplant 2006; 15 (Suppl 1): S111-S117.
12. Humphreys BD, Duffield JD, Bonventre JV. Renal stem cells in recovery from acute kidney injury. Minerva Urol Nefrol 2006; 58: 13-21.
13. Elfenbein GJ. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: Which to choose? Pediatr Transplant 2005; 9 (Suppl 7): 37-47.
14. Fruehauf S, Seeger T, Topaly J. Innovative strategies for PBPC mobilization. Cytotherapy 2005; 7: 438-446.
15. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: Characteristics and clinical applications. Folia Histochem Cytobiol 2006; 44: 215-230.
16. Koide Y, Morikawa S, Mabuchi Y, Muguruma Y, Hiratsu E, Hasegawa K et al. Two distinct stem cell lineages in murine bone marrow. Stem Cells 2007: 11.
17. Sottile V. Bone marrow as a source of stem cells and germ cells? Perspectives for transplantation. Cell Tissue Res 2007: 10.
18. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81-88.
19. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998; 80: 1745-1757.
20. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18: 1417-1426.
21. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998; 16: 406-413.
22. Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promote recovery after spinal cord injury in rat. J Neurotrauma 2006; 23: 1379-1391.
23. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol Imaging 2005; 4: 143-164.
24. Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti PS, Smith DJ et al. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys Med Biol 2005; 50: 5421-5441.
25. Adonai N, Nguyen KN, Walsh J, Iyer M, Toyokuni T, Phelps ME et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci USA 2002; 99: 3030-3035.
26. Mizrahi A, Lu J, Irving R, Feng G, Katz LC. In vivo imaging of juxtaglomerular neuron turnover in the mouse olfactory bulb. Proc Natl Acad Sci USA 2006; 103: 1912-1917.
27. Blanchet PJ, Konitsiotis S, Mochizuki H, Pluta R, Emerich DF, Chase TN et al. Complications of a trophic xenotransplant approach in Parkinsonian monkeys. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 607-612.
28. Duan WM, Brundin P, Widner H. Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat. Neuroscience 1997; 77: 599-609.
29. Philips MF, Muir JK, Saatman KE, Raghupathi R, Lee VM, Trojanowski JQ et al. Survival and integration of transplanted postmitotic human neurons following experimental brain injury in immunocompetent rats. J Neurosurg 1999; 90: 116-124.
30. Remy S, Canova C, Daguin-Nerriere V, Martin C, Melchior B, Neveu I et al. Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain. Xenotransplantation 2001; 8: 136-148.
31. Wood ML, Hardy PA. Proton relaxation enhancement. J Magn Reson Imaging 1993; 3: 149-156.
32. Jendelova P, Herynek V, Urdzíkova L, Glogarova K, Rahmatova S, Fales I et al. MR tracking of human CD34+ progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain. Cell Transplantation 2005; 14: 173-182.
33. Jendelova P, Herynek V, De Croos J, Glogarova K, Andersson B, Hájek M et al. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med 2003; 50: 767-776.
34. Jendelova P, Herynek V, Urdzikova L, Glogarova K, Kroupova J, Bryja V et al. MR tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 2004; 76: 232-243.
35. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004; 3: 24-32.
36. Frank JA Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480-487.
37. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Focking M et al. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 100 1073-1078.
38. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-846.
39. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JW et al. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 2003; 50: 275-282.
40. Horak D, Sykova E, Babic M, Jendelova P, Hajek M (inventors) Superparamagnetic iron oxide nanoparticles with modified surface and their use as probes for stem cell labeling. Patent application no: PV 1006-120, Czech Republic 2006.
41. Glogarova K, Babic M, Herynek V, Horak D, Amemori T, Lesny P et al. Labeling efficiency and viability of stem cells cultured with dextran-coated and polycation-bound iron oxide nanoparticles. MAGMA (in press).
42. Zhang J, Zhu J, Bu X, Cushion M, Kinane TB, Avraham H et al. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. Mol Biol Cell 2005; 16: 824-834.
43. Horak D, Babic M, Jendelova P, Herynek V, Trchova M, Pientka Z et al. D-Mannose-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem (in press).
44. Allen M, Bulte JW, Liepold L, Basu G, Zywicke HA, Frank JA et al. Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med 2005; 54: 807-812.
45. Bulte JW, Zhang SC, van Gelderen P, Herynek V, Jordan EK, Duncan ID et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999; 96: 15256-15261.
46. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005; 54: 769-774.
47. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000; 290: 1775-1779.
48. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96: 10711-10716.
49. Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 2006; 199: 56-66.
50. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 2005; 136: 161-169.
51. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H et al. Neuroprotection by PIGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006; 129 (Part 10): 2734-2745.
52. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 2006; 84: 1495-1504.
53. Shyu WC, Chen CP, Lin SZ, Lee YJ, Li H. Efficient tracking of non-iron-labeled mesenchymal stem cells with serial MRI in chronic stroke rats. Stroke 2006; 38: 367-374.
54. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop JD et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002; 96: 2199-2204.
55. Sykova E, Jendelova P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann N Y Acad Sci 2005; 1049: 146-160.
56. Sykova E, Jendelova P, Urdzikova L, Lesny P, Hejcl A. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol 2006; 26: 1111-1127.
57. Sykova E, Homola A, Mazanec R, Lachman H, Langkramer Konradova S, Kobylka P et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15: 675-687.
58. Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 2005; 11: 913-922.
59. Moviglia GA, Fernandez Vina R, Brizuela JA, Saslavsky J, Vrsalovic F, Varela G et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 2006; 8: 202-209.
60. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R et al. Autologous mesenchymal stem cells: Clinical applications in amyotrophic lateral sclerosis. Neurol Res 2006; 28: 523-526.
61. Sykova E, Jendelova P. In vivo tracking of stem cells in brain and spinal cord injury. Prog Brain Res (in press).